The Radiation of Age-Related Macular Degeneration (ROARMD) study

D. Marcus, C. Sheils, S. Burch, D. Bates, Maribeth H Johnson

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose. The ROARMD study is a prospective, randomized trial designed to determine whether low dose, external beam irradiation is effective in the treatment of choroidal neovascularization (CNV) complicating age-related macular degeneration (ARMD). Methods. Thirty one patients with active CNV secondary to ARMD have been enrolled. Patients with classic, well-defined juxta or extrafoveal lesions were randomized to laser alone versus laser plus adjuvant radiation. Patients with subfoveal or occult lesions were randomized to observation versus radiation. Eight patients with recurrent CNV were non-randomized and treated. Fourteen Gy are administered in 7 fractions via a custom designed collimator. Small field, CT-guided treatment planning is used to precisely administer macular radiation while limiting lens involvement. Fluorescein angiography, visual acuity, contrast sensitivity and visual field were analyzed. Results. At 3 months follow-up, 50% of non-randomized treated patients with recurrent CNV demonstrate stable (within 2 lines of baseline) visual acuity, while 50% of this group demonstrate a loss of 3 lines. Analysis of contrast sensitivity and visual acuity for randomized groups at 3 months follow-up demonstrate no statistically significant harmful or beneficial effects. No adverse effects of radiation were seen. Conclusions. Further follow-up and enrollment in a prospective, randomized manner is necessary to determine the effect of radiation in this disease.

Original languageEnglish (US)
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
StatePublished - Feb 15 1996

Fingerprint

Macular Degeneration
Choroidal Neovascularization
Radiation
Visual Acuity
Contrast Sensitivity
Radiation Effects
Lasers
Fluorescein Angiography
Visual Fields
Lenses
Observation
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

The Radiation of Age-Related Macular Degeneration (ROARMD) study. / Marcus, D.; Sheils, C.; Burch, S.; Bates, D.; Johnson, Maribeth H.

In: Investigative Ophthalmology and Visual Science, Vol. 37, No. 3, 15.02.1996.

Research output: Contribution to journalArticle

@article{811786ebbd13414f88ee4c45e6271b86,
title = "The Radiation of Age-Related Macular Degeneration (ROARMD) study",
abstract = "Purpose. The ROARMD study is a prospective, randomized trial designed to determine whether low dose, external beam irradiation is effective in the treatment of choroidal neovascularization (CNV) complicating age-related macular degeneration (ARMD). Methods. Thirty one patients with active CNV secondary to ARMD have been enrolled. Patients with classic, well-defined juxta or extrafoveal lesions were randomized to laser alone versus laser plus adjuvant radiation. Patients with subfoveal or occult lesions were randomized to observation versus radiation. Eight patients with recurrent CNV were non-randomized and treated. Fourteen Gy are administered in 7 fractions via a custom designed collimator. Small field, CT-guided treatment planning is used to precisely administer macular radiation while limiting lens involvement. Fluorescein angiography, visual acuity, contrast sensitivity and visual field were analyzed. Results. At 3 months follow-up, 50{\%} of non-randomized treated patients with recurrent CNV demonstrate stable (within 2 lines of baseline) visual acuity, while 50{\%} of this group demonstrate a loss of 3 lines. Analysis of contrast sensitivity and visual acuity for randomized groups at 3 months follow-up demonstrate no statistically significant harmful or beneficial effects. No adverse effects of radiation were seen. Conclusions. Further follow-up and enrollment in a prospective, randomized manner is necessary to determine the effect of radiation in this disease.",
author = "D. Marcus and C. Sheils and S. Burch and D. Bates and Johnson, {Maribeth H}",
year = "1996",
month = "2",
day = "15",
language = "English (US)",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - The Radiation of Age-Related Macular Degeneration (ROARMD) study

AU - Marcus, D.

AU - Sheils, C.

AU - Burch, S.

AU - Bates, D.

AU - Johnson, Maribeth H

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose. The ROARMD study is a prospective, randomized trial designed to determine whether low dose, external beam irradiation is effective in the treatment of choroidal neovascularization (CNV) complicating age-related macular degeneration (ARMD). Methods. Thirty one patients with active CNV secondary to ARMD have been enrolled. Patients with classic, well-defined juxta or extrafoveal lesions were randomized to laser alone versus laser plus adjuvant radiation. Patients with subfoveal or occult lesions were randomized to observation versus radiation. Eight patients with recurrent CNV were non-randomized and treated. Fourteen Gy are administered in 7 fractions via a custom designed collimator. Small field, CT-guided treatment planning is used to precisely administer macular radiation while limiting lens involvement. Fluorescein angiography, visual acuity, contrast sensitivity and visual field were analyzed. Results. At 3 months follow-up, 50% of non-randomized treated patients with recurrent CNV demonstrate stable (within 2 lines of baseline) visual acuity, while 50% of this group demonstrate a loss of 3 lines. Analysis of contrast sensitivity and visual acuity for randomized groups at 3 months follow-up demonstrate no statistically significant harmful or beneficial effects. No adverse effects of radiation were seen. Conclusions. Further follow-up and enrollment in a prospective, randomized manner is necessary to determine the effect of radiation in this disease.

AB - Purpose. The ROARMD study is a prospective, randomized trial designed to determine whether low dose, external beam irradiation is effective in the treatment of choroidal neovascularization (CNV) complicating age-related macular degeneration (ARMD). Methods. Thirty one patients with active CNV secondary to ARMD have been enrolled. Patients with classic, well-defined juxta or extrafoveal lesions were randomized to laser alone versus laser plus adjuvant radiation. Patients with subfoveal or occult lesions were randomized to observation versus radiation. Eight patients with recurrent CNV were non-randomized and treated. Fourteen Gy are administered in 7 fractions via a custom designed collimator. Small field, CT-guided treatment planning is used to precisely administer macular radiation while limiting lens involvement. Fluorescein angiography, visual acuity, contrast sensitivity and visual field were analyzed. Results. At 3 months follow-up, 50% of non-randomized treated patients with recurrent CNV demonstrate stable (within 2 lines of baseline) visual acuity, while 50% of this group demonstrate a loss of 3 lines. Analysis of contrast sensitivity and visual acuity for randomized groups at 3 months follow-up demonstrate no statistically significant harmful or beneficial effects. No adverse effects of radiation were seen. Conclusions. Further follow-up and enrollment in a prospective, randomized manner is necessary to determine the effect of radiation in this disease.

UR - http://www.scopus.com/inward/record.url?scp=0008680249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0008680249&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0008680249

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -